Literature DB >> 20138921

Lack of involvement of alpha-synuclein in unconditioned anxiety in mice.

Yolanda Peña-Oliver1, Vladimir L Buchman, David N Stephens.   

Abstract

Alpha-synuclein is implicated in the pathology of Parkinson disease (PD) and is involved in synaptic function, particularly in presynaptic events in dopamine (DA) synapses. Recently, a role for alpha-synuclein in reward and addiction, especially in alcoholism, has been reported. Since PD and alcohol dependence present a strong comorbidity with anxiety disorders, a role for alpha-synuclein in anxiety has been proposed. The aim of the present investigation was to study the involvement of alpha-synuclein in anxiety by testing alpha-synuclein knock out and wild type mice in three different emotionality tests: the open field, the elevated plus maze and the light-dark box. Alpha-synuclein knock out mice and wild type controls displayed consistently similar emotionality profiles in all the tests, suggesting a lack of involvement of alpha-synuclein in unconditioned anxiety in mice. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138921      PMCID: PMC3132456          DOI: 10.1016/j.bbr.2010.01.049

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  47 in total

1.  Double-knockout mice for alpha- and beta-synucleins: effect on synaptic functions.

Authors:  Sreeganga Chandra; Francesco Fornai; Hyung-Bae Kwon; Umar Yazdani; Deniz Atasoy; Xinran Liu; Robert E Hammer; Giuseppe Battaglia; Dwight C German; Pablo E Castillo; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

2.  alpha-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats.

Authors:  Tiebing Liang; John Spence; Lixiang Liu; Wendy N Strother; Hwai Wen Chang; Julie A Ellison; Lawrence Lumeng; Ting-Kai Li; Tatiana Foroud; Lucinda G Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-28       Impact factor: 11.205

3.  Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.

Authors:  Darren C Robertson; Oliver Schmidt; Natalia Ninkina; Paul A Jones; John Sharkey; Vladimir L Buchman
Journal:  J Neurochem       Date:  2004-06       Impact factor: 5.372

4.  Psychiatric comorbidity in a population of Parkinson's disease patients.

Authors:  A Nuti; R Ceravolo; A Piccinni; G Dell'Agnello; G Bellini; G Gambaccini; C Rossi; C Logi; L Dell'Osso; U Bonuccelli
Journal:  Eur J Neurol       Date:  2004-05       Impact factor: 6.089

5.  Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

Authors:  Marie-Christine Chartier-Harlin; Jennifer Kachergus; Christophe Roumier; Vincent Mouroux; Xavier Douay; Sarah Lincoln; Clotilde Levecque; Lydie Larvor; Joris Andrieux; Mary Hulihan; Nawal Waucquier; Luc Defebvre; Philippe Amouyel; Matthew Farrer; Alain Destée
Journal:  Lancet       Date:  2004 Sep 25-Oct 1       Impact factor: 79.321

6.  Strain differences in activity and emotionality do not account for differences in learning and memory performance between C57BL/6 and DBA/2 mice.

Authors:  J Podhorna; R E Brown
Journal:  Genes Brain Behav       Date:  2002-05       Impact factor: 3.449

7.  Deletion of multimerin-1 in alpha-synuclein-deficient mice.

Authors:  Christian G Specht; Ralf Schoepfer
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

8.  The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia.

Authors:  Juan J Zarranz; Javier Alegre; Juan C Gómez-Esteban; Elena Lezcano; Raquel Ros; Israel Ampuero; Lídice Vidal; Janet Hoenicka; Olga Rodriguez; Begoña Atarés; Verónica Llorens; Estrella Gomez Tortosa; Teodoro del Ser; David G Muñoz; Justo G de Yebenes
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

9.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines.

Authors:  J Crawley; F K Goodwin
Journal:  Pharmacol Biochem Behav       Date:  1980-08       Impact factor: 3.533

10.  Distribution of alpha- and gamma-synucleins in the adult rat brain and their modification by high-dose cocaine treatment.

Authors:  Maria S Brenz Verca; Amine Bahi; Frederic Boyer; George C Wagner; Jean-Luc Dreyer
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386

View more
  10 in total

1.  Impaired spatial and working memory in ageing mice with targeted inactivation of α-synuclein gene.

Authors:  V S Kokhan; G I Van'kin; N N Ninkina; T A Shelkovnikova; S O Bachurin
Journal:  Dokl Biol Sci       Date:  2012-01-07

Review 2.  Synuclein modulation of monoamine transporters.

Authors:  Adam W Oaks; Anita Sidhu
Journal:  FEBS Lett       Date:  2011-03-23       Impact factor: 4.124

3.  Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.

Authors:  Eileen Ruth S Torres; Milos Stanojlovic; Moriel Zelikowsky; Jana Bonsberger; Sindalana Hean; Caitlin Mulligan; Leonie Baldauf; Sheila Fleming; Eliezer Masliah; Marie-Francoise Chesselet; Michael S Fanselow; Franziska Richter
Journal:  Neurobiol Dis       Date:  2021-08-11       Impact factor: 7.046

4.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

Review 5.  Alpha-synuclein modulates dopamine neurotransmission.

Authors:  Brittany Butler; Danielle Sambo; Habibeh Khoshbouei
Journal:  J Chem Neuroanat       Date:  2016-06-19       Impact factor: 3.052

6.  Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic function.

Authors:  Kaitlin F Farrell; Sesha Krishnamachari; Ernesto Villanueva; Haiyan Lou; Tshianda N M Alerte; Eloise Peet; Robert E Drolet; Ruth G Perez
Journal:  J Neurochem       Date:  2013-11-20       Impact factor: 5.372

7.  Ginsenoside Rb1 prevents MPTP-induced changes in hippocampal memory via regulation of the α-synuclein/PSD-95 pathway.

Authors:  Shaogang Qu; Xingjun Meng; Yan Liu; Xiuping Zhang; Yunlong Zhang
Journal:  Aging (Albany NY)       Date:  2019-04-04       Impact factor: 5.682

8.  Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice.

Authors:  Viktor S Kokhan; Gennadiy I Van'kin; Sergey O Bachurin; Inna Yu Shamakina
Journal:  BMC Neurosci       Date:  2013-05-14       Impact factor: 3.288

9.  Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function.

Authors:  Adam W Oaks; Maya Frankfurt; David I Finkelstein; Anita Sidhu
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

10.  Synucleins antagonize endoplasmic reticulum function to modulate dopamine transporter trafficking.

Authors:  Adam W Oaks; Nicholas Marsh-Armstrong; Jessica M Jones; Joel J Credle; Anita Sidhu
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.